Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,216) with videos related to
Page
of 122
Sort By:
Journal of Neuro-Oncology
|
August 23, 2018
Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study
Stephanie R Rice, Søren M Bentzen, Andrew Hanna, et al.
Neuro-Oncology
|
November 4, 2024
Efficacy of 3D-TSE sequence-based radiosurgery in prolonging time to distant intracranial failure: A session-wise analysis in a histology-diverse patient cohort
Eyub Y Akdemir, Selin Gurdikyan, Muni Rubens, et al.
Biochimica Et Biophysica Acta. Biomembranes
|
June 29, 2017
An update on minding the gap in cancer
Marc Mesnil, Trond Aasen, Jonathan Boucher, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2026
Patterns of failure after definitive ablative 5-fraction stereotactic body radiation therapy for inoperable pancreatic ductal adenocarcinoma
Michael D Chuong, Roberto Herrera, Jason E Extein, et al.
Molecular Cancer Therapeutics
|
July 14, 2011
PF-04691502, a potent and selective oral inhibitor of PI3K and mTOR kinases with antitumor activity
Jing Yuan, Pramod P Mehta, Min-Jean Yin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study
John F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
Advances in Radiation Oncology
|
November 2, 2019
Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933
Joseph A Bovi, Stephanie L Pugh, David Sabsevitz, et al.
Neuro-Oncology
|
November 11, 2017
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
Prakash Chinnaiyan, Minhee Won, Patrick Y Wen, et al.
Neuro-Oncology
|
February 13, 2010
A multigene predictor of outcome in glioblastoma
Howard Colman, Li Zhang, Erik P Sulman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 15, 2023
Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614
Jeffrey S Wefel, Snehal Deshmukh, Paul D Brown, et al.
Page
of 122
Search research articles
Search
Showing results (1061-1070 of 1,216) with videos related to
Sort By:
Page
of 122
Journal of Neuro-Oncology
|
August 23, 2018
Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study
Stephanie R Rice, Søren M Bentzen, Andrew Hanna, et al.
Neuro-Oncology
|
November 4, 2024
Efficacy of 3D-TSE sequence-based radiosurgery in prolonging time to distant intracranial failure: A session-wise analysis in a histology-diverse patient cohort
Eyub Y Akdemir, Selin Gurdikyan, Muni Rubens, et al.
Biochimica Et Biophysica Acta. Biomembranes
|
June 29, 2017
An update on minding the gap in cancer
Marc Mesnil, Trond Aasen, Jonathan Boucher, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2026
Patterns of failure after definitive ablative 5-fraction stereotactic body radiation therapy for inoperable pancreatic ductal adenocarcinoma
Michael D Chuong, Roberto Herrera, Jason E Extein, et al.
Molecular Cancer Therapeutics
|
July 14, 2011
PF-04691502, a potent and selective oral inhibitor of PI3K and mTOR kinases with antitumor activity
Jing Yuan, Pramod P Mehta, Min-Jean Yin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study
John F de Groot, Kathleen R Lamborn, Susan M Chang, et al.
Advances in Radiation Oncology
|
November 2, 2019
Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933
Joseph A Bovi, Stephanie L Pugh, David Sabsevitz, et al.
Neuro-Oncology
|
November 11, 2017
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
Prakash Chinnaiyan, Minhee Won, Patrick Y Wen, et al.
Neuro-Oncology
|
February 13, 2010
A multigene predictor of outcome in glioblastoma
Howard Colman, Li Zhang, Erik P Sulman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 15, 2023
Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614
Jeffrey S Wefel, Snehal Deshmukh, Paul D Brown, et al.
Page
of 122